Expanded Access to GLP-1 Weight-Loss Drugs for Millions of Older Adults

How is the new federal pilot program expanding access to GLP-1 weight-loss medications? This program allows millions of older adults to qualify for prescription weight-loss drugs with just a $50 copay, marking a significant change since federal health programs previously excluded coverage for such medications. To be eligible, individuals must be 18 years or older, have prescription drug coverage, meet a qualifying BMI, and use the medication alongside structured nutrition and physical activity. Additionally, factors like pre-diabetes, high blood pressure, and chronic kidney disease can influence eligibility, and prescriptions will require prior authorization. This pilot program is set to run through the end of 2027, providing access to drugs that can exceed $1,000, making them more affordable for those in need.

For older adults looking to manage their weight and improve their health, this shift in prescription coverage opens up new possibilities for treatment and support.

For expert guidance on insurance and protecting what matters most, connect with Shalette Freeman, insurance advisor at PFS.